Medical News

RSS

Accuray announces pricing of $100 million convertible senior notes due 2018

Accuray Incorporated today announced the pricing of its offering of $100 million aggregate principal amount of 3.50% convertible senior notes due 2018.

10 Feb 2013

Researchers develop special version of iDichotic for patients with schizophrenia

Two years ago, researcher Josef Bless was listening to music on his phone when he suddenly had an idea. "I noticed that the sounds of the different instruments were distributed differently between the ears, and it struck me that this was very similar to the tests we routinely use in our laboratory to measure brain function. In dichotic listening, each ear is presented with a different syllable at the same time and the listener has to say which syllable seems clearest. The test indicates which side of the brain is most active during language processing," Bless explains.

10 Feb 2013

TGFβ inhibition enhances chemotherapy action against triple negative breast cancer

Due to chemotherapy resistance and a high rate of relapse, triple negative cancers are among the most difficult breast cancers to treat. In this issue of the Journal of Clinical Investigation, researchers led by Carlos Arteaga at Vanderbilt University identified a protein, TGF-β, that is highly expressed in triple negative breast cancer cells after chemotherapy.

10 Feb 2013

Social networking sites could effectively help prevent HIV infection among at-risk groups

Facebook and other social networking technologies could serve as effective tools for preventing HIV infection among at-risk groups, new UCLA research suggests.

9 Feb 2013

Weekend reading: Mental health discrimination; A doctor faces hard questions; Long-term outlook for health care jobs

"When I had cancer, I got cards and flowers," Karen Kangas' sign reads. "When I was diagnosed with bipolar disorder, I got no cards and a pink slip." A picture of Kangas holding the sign hangs in the state Capitol complex, part of an exhibit called "Discrimination: A Roadblock to Recovery."

9 Feb 2013

Neurocrine Biosciences fourth quarter net income increases to $9.5 million

Neurocrine Biosciences, Inc. today announced its financial results for the quarter and year ended December 31, 2012.

9 Feb 2013

LPA genetic variant increases risk of heart valve calcification

Researchers have found a genetic variant that doubles the likelihood that people will have calcium deposits on their aortic valve. Such calcification, if it becomes severe, can cause narrowing or a blockage of the aortic valve, a condition called aortic stenosis.

9 Feb 2013

Study finds reason why patients with chronic pain often suffer from impaired short -term memory

A group of Portuguese researchers from IBMC and FMUP at the University of Porto has found the reason why patients with chronic pain often suffer from impaired short -term memory.

9 Feb 2013

Marijuana may double stroke risk in young adults

Marijuana, the most widely used illicit drug, may double stroke risk in young adults, according to research presented at the American Stroke Association's International Stroke Conference 2013.

9 Feb 2013

First Edition: February 8, 2013

Today's early morning highlights from the major news organizations, including reports about Marilyn Tavenner's nomination to run Medicare and the Catholic bishops' rejection of the Obama administration's contraception plan announced last week.

9 Feb 2013

Positive data from Oncolytics' REOLYSIN Phase 2 combination trial on SCCLC

Oncolytics Biotech Inc. today announced results examining percent overall tumour shrinkage data from its U.S. Phase 2 clinical trial in patients with squamous cell carcinoma of the lung (SCCLC) using intravenous administration of REOLYSIN in combination with carboplatin and paclitaxel (REO 021).

9 Feb 2013

Gilead Sciences acquires YM BioSciences

Gilead Sciences, Inc. today announced that it has completed its acquisition of YM BioSciences Inc.

9 Feb 2013

Political cartoon: 'Coming To Your Neighborhood Soon?'

Kaiser Health News provides a fresh take on health policy developments with "Coming To Your Neighborhood Soon?" By Matt Wuerker, Politico.

9 Feb 2013

Planmed Verity Extremity Scanner receives FDA clearance

Planmed Verity is designed to find subtle extremity fractures during the first visit to the clinic – the types of fractures that have most commonly been missed when only using 2D radiographs.

From Planmed Oy 9 Feb 2013

Viewpoints: 'Empty budget gestures'; GOP should endorse 'doomsday' sequester; 'Imagined dangers' imperil vaccine successes

President Obama on Tuesday called on Congress to put off -- again -- the start of the "sequester," a series of across-the-board spending cuts that would save $1.2 billion over 10 years.

9 Feb 2013

Drugs that target retromer pathway could help prevent or treat Parkinson's

Columbia University Medical Center (CUMC) researchers have identified a protein trafficking defect within brain cells that may underlie common non-familial forms of Parkinson's disease.

9 Feb 2013

Older adults with COPD more frequently use benzodiazepines

A popular class of drugs commonly used to treat sleep and mood symptoms continues to be frequently prescribed despite being known to have potentially life-threatening side effects.

9 Feb 2013

CtBP may play a key role in aggressive forms of breast cancer

A protein associated with conditions of metabolic imbalance, such as diabetes and obesity, may play a role in the development of aggressive forms of breast cancer, according to new findings by researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, and their colleagues.

9 Feb 2013

U.S. foreign aid is 'good value'

"Unfortunately, most Americans don't realize what a good value our foreign assistance efforts are," and "most would be surprised to learn that foreign aid amounts to only about one percent of the federal budget," Carolyn Woo, president and CEO of Catholic Relief Services, writes in a Baltimore Sun opinion piece.

9 Feb 2013

Academic medical centers play an integral role in developing new treatments and cures

As an internationally recognized researcher into aging and dementia, Suzanne Craft is keenly aware of the importance of volunteers in clinical studies.

9 Feb 2013